GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
U.S. military buildup in Middle East includes USS Gerald R. Ford and USS Abraham Lincoln carriers for sustained Iran campaign if Trump orders it, Dana Stroul said....
C.S. Lewis coined the term “Chronological Snobbery” to describe the condition of “uncritical acceptance of the intellectual climate common to......
I awoke this morning at The Oaklander Hotel on the campus of the University of Pittsburgh, a night away from......
